Short description
Biophysical Therapeutics uses computational biology to design new drugs. Its primary targets are cancer, diseases of aging, & aging itself.
Description
Biophysical Therapeutics uses computational biology to design new drugs. It has a pipeline of experimentally-validated new drugs. Its primary targets are cancer, diseases of aging (e.g., Alzheimer's disease), and aging itself. Also pursuing cosmetics. Has a record of discovering new fundamental biology. Owns [by granted patents] invented preclinical, and repurposed clinical, stage drugs. Company has and is prosecuting longevity drug candidates (drugs to slow, halt or reverse aging). A longevity company. Professor George Church (of Harvard Medical School) is an Advisor. Scientist founder, Dr. Michael Forrest, is a Cambridge University biochemistry graduate with a Ph.D. in computer science.
Last funding
Noaccess
Sign in for full access
Total funding
$$121212
Sign in for full access
Location
Wilmington, Delaware, United States, North America
Founded on
October 24, 2022
Non-profit?
No
Acquired?
No
Employees count
1-10
Investors
Cannot Access, Noaccess, Nopepepe
Sign in for full access
Founders
Michael Forrest